CAS: 180288-69-1 - Trastuzumab
- Synonyms:
- Trastuzumab [USAN:INN]
- Herceptin
- Immunoglobulin G 1 (human-mouse monoclonal rhuMab HER2gamma1-chain antihuman p185(sup c-erbB2) receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
- Unii-P188Anx8Ck
- Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 gamma1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Trastuzumab REF: TM-T9912CAS: 180288-69-1 | 98% - 99.50% | 152.00 €~1,831.00 € | Mon 13 Jan 25 |
 | Trastuzumab - 20mg/ml in PBS REF: 3D-FT65040CAS: 180288-69-1 | Min. 95 Area-% | 237.00 €~1,676.00 € | Wed 15 Jan 25 |
Trastuzumab
CAS:180288-69-1
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2.
Purity:
98% - 99.50%
Color and Shape:
Liquid
Molecular weight:
Approximately 145.53 kDa
Ref: TM-T9912
| 1mg | 152.00 € | ||
| 5mg | 511.00 € | ||
| 10mg | 640.00 € | ||
| 25mg | 1,009.00 € | ||
| 50mg | 1,364.00 € | ||
| 100mg | 1,831.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Trastuzumab - 20mg/ml in PBS
CAS:180288-69-1
Monoclonal antibody against HER2 for breast cancer treatment
Purity:
Min. 95 Area-%
Color and Shape:
Clear Liquid
Ref: 3D-FT65040
| 1mg | 237.00 € | ||
| 10mg | 801.00 € | ||
| 25mg | 1,676.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
